Search Results
Dr. Tolaney on Pembrolizumab Plus Eribulin in TNBC
Dr. Sara Tolaney on Eribulin Plus Pembrolizumab for Metastatic Triple-Negative Breast Cancer
A Study Investigating Pembrolizumab in Combination With Eribulin in TNBC
Dr. Tolaney on Abemaciclib Plus Pembrolizumab for HR+, HER2- Breast Cancer
PD-1 therapy with eribulin for triple negative MBC
Dr. Nanda On Pembrolizumab Potential for TNBC
Eribulin in Metastatic TNBC: Real-World Data
SABCS 2016 - Sara Tolaney
Eribulin’s Role in Triple-Negative Breast Cancer
Phase II Results for Pembrolizumab Monotherapy in Metastatic TNBC
Results for Pembrolizumab Plus Standard Neoadjuvant Therapy for High-Risk Breast Cancer
Eribulin as Treatment for Metastatic Breast Cancer